<DOC>
	<DOC>NCT00878540</DOC>
	<brief_summary>The purpose of this study is to determine metabolic changes upon a 7 day medication of 30 mg mirtazapine per day in healthy subjects.</brief_summary>
	<brief_title>Short-term Metabolic Effects of Mirtazapine in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>Male sex Age 2025 years Somatically and mentally healthy Normal body weight (body mass index (BMI)18.525) Smoking within the last 6 months Medication within last 6 months Current or former psychiatric illness Positive family history (first grade relatives) for metabolic diseases Alcohol abuse Current or former illicit drug abuse Current or former drug abuse Known intolerance to, or former prescription of study medication Participation in other clinical trials at the same time or participation in clinical trials associated with administration of a drug within the last 6 months Homelessness Shift work within last 12 months Known hypersensitivity to mirtazapine or other components of the drug given Known epilepsy; glaucoma; liver, kidney, or heart disease; urinary dysfunction; hypotonia; diabetes or any other metabolic disease Known hematologic disease, especially agranulocytosis or leukopenia Blood donation within last 6 months prior to the begin of the study Hemoglobin below 13.5 mg/dL</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>mirtazapine</keyword>
	<keyword>metabolism</keyword>
	<keyword>depression</keyword>
	<keyword>Healthy males</keyword>
</DOC>